tert-Butyl (8-bromoquinolin-2-yl)carbamate

98%

Reagent Code: #152065
fingerprint
CAS Number 1447608-01-6

science Other reagents with same CAS 1447608-01-6

blur_circular Chemical Specifications

scatter_plot Molecular Information
Weight 323.19 g/mol
Formula C₁₄H₁₅BrN₂O₂
badge Registry Numbers
MDL Number MFCD25542359
thermostat Physical Properties
Boiling Point 389.1±22.0 °C at 760 mmHg
inventory_2 Storage & Handling
Storage 2-8°C, dry

description Product Description

Used as an intermediate in pharmaceutical synthesis, particularly in the development of kinase inhibitors and other bioactive molecules. Its structure supports the formation of nitrogen-containing heterocyclic compounds, which are common in drug design for oncology and infectious diseases. The tert-butyl carbamate group acts as a protecting group for amines during multi-step syntheses, allowing selective reactions at other functional sites. The bromoquinoline moiety enables further functionalization via cross-coupling reactions such as Suzuki or Buchwald-Hartwig aminations, making it valuable in medicinal chemistry for building complex molecular architectures.

Available Sizes & Pricing

Size Availability Unit Price Quantity
50mg
10-20 days ฿7,880.00
100mg
10-20 days ฿13,360.00
250mg
10-20 days ฿21,290.00
tert-Butyl (8-bromoquinolin-2-yl)carbamate
No image available

Used as an intermediate in pharmaceutical synthesis, particularly in the development of kinase inhibitors and other bioactive molecules. Its structure supports the formation of nitrogen-containing heterocyclic compounds, which are common in drug design for oncology and infectious diseases. The tert-butyl carbamate group acts as a protecting group for amines during multi-step syntheses, allowing selective reactions at other functional sites. The bromoquinoline moiety enables further functionalization via

Used as an intermediate in pharmaceutical synthesis, particularly in the development of kinase inhibitors and other bioactive molecules. Its structure supports the formation of nitrogen-containing heterocyclic compounds, which are common in drug design for oncology and infectious diseases. The tert-butyl carbamate group acts as a protecting group for amines during multi-step syntheses, allowing selective reactions at other functional sites. The bromoquinoline moiety enables further functionalization via cross-coupling reactions such as Suzuki or Buchwald-Hartwig aminations, making it valuable in medicinal chemistry for building complex molecular architectures.

Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...